Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. PPARγ
3. PPARγ in adipocytes
4. PPARγ in glucose homeostasis
5. PPARγ in macrophages
6. PPARγ targeting drug
7. PPARγ in MAFLD
8. Disclosures
9. Thank you for listening

Topics Covered

• Functions of PPARγ
• Role of PPARγ in adipocytes and glucose homeostasis
• Role of PPARγ in macrophage functions
• PPARγ targeting drugs
• PPARγ in MAFLD

Links

Series:

• Nuclear Receptors as Common Therapeutic Targets

Categories:

• Cancer
• Cell Biology

Therapeutic Areas:

• Cardiovascular & Metabolic
• Oncology

Talk Citation

Merk, D. (2026, October 29). Peroxisome proliferator-activated receptors: PPARγ (NR1C3) – biological role and drugs [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 29, 2026, from https://doi.org/10.69645/LKCG8126.
Export Citation (RIS)

Publication History

• Published on October 29, 2026

Financial Disclosures

• Daniel Merk discloses affiliations with Ludwig-Maximilians-University Munich and the Free State of Bavaria. He is a member of the German Pharmaceutical Society (DPhG) and the German Chemical Society (GDCh). He has received honoraria for lectures, authoring, reviewing, and advisory activities from the DPhG, German Associations of Pharmacists, German Medical Association, Sanofi, Boehringer Ingelheim, ONO Pharmaceuticals, YS Life Science, AVOXA, SpringerNature, Wiley, and the Swiss National Science Foundation (SNF). Additionally, he holds five patents or patent applications related to nuclear receptor modulators and other small molecule drugs. His research is funded by the European Research Council (ERC), Innovative Medicines Initiative (IMI), German Research Foundation (DFG), German Federal Agency for Disruptive Innovation (SPRIN-D), and Immunic AG.